Lenvima is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Eisai Inc.. The primary component is Lenvatinib.
Product ID | 62856-704_0595269f-a64e-45c8-9490-4cecc2a06227 |
NDC | 62856-704 |
Product Type | Human Prescription Drug |
Proprietary Name | Lenvima |
Generic Name | Lenvatinib |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2018-08-15 |
Marketing Category | NDA / NDA |
Application Number | NDA206947 |
Labeler Name | Eisai Inc. |
Substance Name | LENVATINIB |
Active Ingredient Strength | 4 mg/1 |
Pharm Classes | Kinase Inhibitor [EPC], Receptor Tyrosine Kinase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2018-08-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA206947 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-08-15 |
Marketing Category | NDA |
Application Number | NDA206947 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-08-15 |
Ingredient | Strength |
---|---|
LENVATINIB | 4 mg/1 |
SPL SET ID: | f4bedd21-efde-44c6-9d9c-b48b78d7ed1e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
62856-704 | Lenvima | Lenvatinib |
62856-708 | Lenvima | Lenvatinib |
62856-710 | Lenvima | Lenvatinib |
62856-712 | Lenvima | Lenvima |
62856-718 | Lenvima | Lenvima |
62856-720 | Lenvima | Lenvima |
62856-724 | Lenvima | Lenvima |
62856-714 | Lenvima | Lenvima |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LENVIMA 85778136 4744029 Live/Registered |
Eisai R&D Management Co., Ltd. 2012-11-13 |